Immune Response Licensing Magazine Molecular Biology 
Drug Discovery World
MAY 6, 2024
The transfer of technologies from the lab to the market, is no longer purely via IP out licensing, but rather via start-up M&A deals – start-ups being the de-risking vehicle for large corporates. Biotechs such as ourselves and Owkin are leveraging artificial intelligence.” The post Europe: Where is the drug discovery innovation?
Codon
FEBRUARY 13, 2024
doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.
Expert insights. Personalized for you.
147 
Let's personalize your content